Research / MDB / Fundamental state Inspectable configuration
State dimensions Filing 0001441816-21-000051 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.99% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-7.23% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
39.99% · CORE · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
70.01% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-35.45% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
34.75% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
25.29% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 29 states Self-history eligible
Jul 31, 2021 6/7 normalized Level 3 Oct 31, 2021 6/7 normalized Level 3 Jan 31, 2022 6/7 normalized Level 3 Apr 30, 2022 7/7 normalized Level 3 Jul 31, 2022 7/7 normalized Level 3 Oct 31, 2022 7/7 normalized Level 3 Jan 31, 2023 7/7 normalized Level 3 Apr 30, 2023 7/7 normalized Level 3 Jul 31, 2023 7/7 normalized Level 3 Oct 31, 2023 7/7 normalized Level 3 Jan 31, 2024 7/7 normalized Level 3 Apr 30, 2024 7/7 normalized Level 3 Jul 31, 2024 7/7 normalized Level 3 Oct 31, 2024 7/7 normalized Level 3 Jan 31, 2025 7/7 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Decreased
Previous 3.74%
Current 1.99%
Delta -1.75% Cash Generation Decreased
Previous -5.39%
Current -7.23%
Delta -1.84% Growth Increased
Previous 37.76%
Current 39.99%
Delta 2.23% Margin Increased
Previous 69.42%
Current 70.01%
Delta 0.59% Profitability Increased
Previous -38.53%
Current -35.45%
Delta 3.08% R And D Intensity Decreased
Previous 36.06%
Current 34.75%
Delta -1.31% Sbc Intensity Decreased
Previous 26.50%
Current 25.29%
Delta -1.21% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.